Orlando Serrano, PhD, is a senior research scientist at a translational research institute in Seattle, Washington. Following postdoctoral training in cancer biology, he leads a laboratory group developing organoids, primary cell lines, and animal disease models for experimental therapeutic screens. His articles address preclinical laboratory models for Biology Insights. Serrano directs tissue culture pipelines that supply biological assays across several drug discovery programs.